Personal information

Verified email domains

Activities

Works (11)

Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response

Nature Communications
2024-06-27 | Journal article
Contributors: Mason J. Webb; Thanich Sangsuwannukul; Jacob van Vloten; Laura Evgin; Benjamin Kendall; Jason Tonne; Jill Thompson; Muriel Metko; Madelyn Moore; Maria P. Chiriboga Yerovi et al.
Source: check_circle
Crossref

Isocitrate Dehydrogenase Inhibitors in Glioma: From Bench to Bedside

Pharmaceuticals
2024-05-26 | Journal article
Contributors: Merve Hazal Ser; Mason Webb; Anna Thomsen; Ugur Sener
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas

Current Oncology Reports
2024-04 | Journal article
Contributors: Allison R. Valerius; Mason J. Webb; Nouran Hammad; Ugur Sener; Rachna Malani
Source: check_circle
Crossref

Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma

Journal of Immunotherapy and Precision Oncology
2024-02-01 | Journal article
Contributors: Ugur Sener; Mason Webb; William G. Breen; Bryan J. Neth; Nadia N. Laack; David Routman; Paul D. Brown; Anita Mahajan; Kelsey Frechette; Arkadiusz Z. Dudek et al.
Source: check_circle
Crossref

Chimerization of the Anti-Viral CD8+ T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic Virotherapy

2023-11-20 | Preprint
Contributors: Richard Vile; Mason Webb; Jacob van Vloten; Laura Evgin; Thanich Sangsuwannukul; Benjamin Kendall; Jason Tonne; Jill Thompson; Muriel Metko; Madelyn Moore et al.
Source: check_circle
Crossref

Proton craniospinal irradiation with bevacizumab and pembrolizumab for leptomeningeal disease: a case report

CNS Oncology
2023-09-30 | Journal article
Contributors: Mason J Webb; William G Breen; Nadia N Laack; Konstantinos Leventakos; Jian L Campian; Ugur Sener
Source: check_circle
Crossref

Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients

2023-09-20 | Other
Contributors: Mason James Webb; Brian Neff; Daniel Blezek; Jamie J. Van Gompel
Source: check_circle
Crossref

Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma

Pharmaceuticals
2023-05-26 | Journal article
Contributors: Mason J. Webb; Ugur Sener; Richard G. Vile
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Teaching NeuroImage: Intracranial Solitary Fibrous Tumor With Liver Metastasis

Neurology
2023-05-02 | Journal article
Contributors: Mason James Webb; Jian L. Campian; Ugur Sener
Source: check_circle
Crossref

The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma

Pharmaceutics
2023-04-03 | Journal article
Contributors: Bryan J. Neth; Mason J. Webb; Ian F. Parney; Ugur T. Sener
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis

Journal of Neuro-Oncology
2022-11 | Journal article
Contributors: Mason Webb; Derek R. Johnson; Anita Mahajan; Paul Brown; Bryan Neth; Sani H. Kizilbash; Ugur Sener
Source: check_circle
Crossref

Peer review (1 review for 1 publication/grant)

Review activity for Cancers. (1)